Mealey's (September 20, 2019, 12:35 PM EDT) -- SAN FRANCISCO — A federal district court did not abuse it’s discretion in dismissing a medical technology company’s counterclaims for unfair business practices and unjust enrichment against its competitor in the health care professional clothing industry without leave to amend because those counterclaims are superseded by California’s uniform trade secrets law, a Ninth Circuit U.S. Court of Appeals panel ruled Sept. 16 (Strategic Partners Inc. v. Vestagen Protective Technologies Inc., Nos. 17-56789, 17-56897 and 18-55156, 9th Cir., 2019 U.S. App. LEXIS 27819)....